Meropenem therapy failure in Listeria monocytogenes infection
- 13 May 2004
- journal article
- case report
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (6) , 484-486
- https://doi.org/10.1007/s10096-004-1135-3
Abstract
Listeria monocytogenes is highly susceptible to meropenem in vitro, but data on the efficacy of meropenem in clinical cases of listeriosis are scarce. Described here is the case of a child with aplastic anemia who acquired nosocomial listeriosis and failed to respond to initial meropenem therapy. Resolution of fever was not noted after 5 days of therapy with meropenem and, more importantly, clinical worsening was observed during this period. The patient began to improve after ampicillin was introduced to the therapeutic regimen. In total, meropenem was administered for 15 days and ampicillin for 10 days.Keywords
This publication has 18 references indexed in Scilit:
- Therapeutic optionsFEMS Immunology & Medical Microbiology, 2003
- Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage modelJournal of Antimicrobial Chemotherapy, 2003
- Comparative Intracellular (THP-1 Macrophage) and Extracellular Activities of β-Lactams, Azithromycin, Gentamicin, and Fluoroquinolones against Listeria monocytogenes at Clinically Relevant ConcentrationsAntimicrobial Agents and Chemotherapy, 2002
- In vitro activities of 22 antimicrobial agents against Listeria monocytogenes strains isolated in Barcelona, SpainDiagnostic Microbiology and Infectious Disease, 2000
- Listeria monocytogenes meningitis in a penicillin-allergic paediatric rental transplant patientJournal of Infection, 1998
- Treatment of Bacterial MeningitisNew England Journal of Medicine, 1997
- Efficacy of meropenem in experimental meningitisJournal of Antimicrobial Chemotherapy, 1995
- Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 1990
- Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactamsAntimicrobial Agents and Chemotherapy, 1990
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990